Edition:
United States

GeneNews Ltd (GEN.TO)

GEN.TO on Toronto Stock Exchange

0.22CAD
24 May 2017
Change (% chg)

$-0.01 (-6.38%)
Prev Close
$0.23
Open
$0.24
Day's High
$0.24
Day's Low
$0.21
Volume
581,555
Avg. Vol
485,973
52-wk High
$0.57
52-wk Low
$0.14

Latest Key Developments (Source: Significant Developments)

Genenews Q1 loss per share $0.02
Thursday, 11 May 2017 08:00am EDT 

May 11 (Reuters) - Genenews Ltd :Genenews announces q1-2017 financial results & provides progress update.Q1 loss per share $0.02.Q1 revenue $200,000 versus $100,000.  Full Article

Genenews reports Q4 EPS $0.02
Monday, 3 Apr 2017 09:15am EDT 

Genenews Ltd : Genenews announces fourth quarter and full year 2016 financial results . Qtrly earnings per share $0.02 .Total revenue for three-months ended December 31, 2016, was approximately $0.3 million, compared to nil in same period in 2016.  Full Article

Genenews announces settlement agreement with HDL Liquidating Trust
Thursday, 9 Mar 2017 04:30pm EST 

Genenews Ltd : Genenews announces settlement agreement with hdl liquidating trust . Genenews ltd -unit reached settlement to resolve outstanding $2 million secured demand promissory note from acquisitions of innovative diagnostic laboratory . Says unit to pay trust settlement amount of $2.1 million .Genenews ltd says agreement will be submitted to bankruptcy court for review and is expected to be approved before end of march 2017.  Full Article

Genenews announces proposed private placement of convertible debentures
Friday, 2 Dec 2016 05:24pm EST 

Genenews Ltd : Genenews announces proposed private placement of convertible debentures . Genenews Ltd- To complete brokered private placement of convertible unsecured debentures for gross proceeds of up to $3 million on a "best efforts" basis . Genenews Ltd - Proceeds of sale of debentures will be used to repay current debt and payables, and to launch new products .Genenews - Debentures will have a term of three years and bear interest at a rate of 8% per annum, payable semi-annually in arrears, in cash.  Full Article

GeneNews qtrly loss per share $0.02
Thursday, 11 Aug 2016 07:45am EDT 

GeneNews Ltd : Announces Q2-2016 financial results .Qtrly loss per share $0.02.  Full Article

Genenews announces Q1 loss per share $0.05
Wednesday, 15 Jun 2016 07:30am EDT 

Genenews : Announces filing of Q1 2016 financial results .Q1 loss per share $0.05.  Full Article

GeneNews Limited Announces Private Placement Financing of up to $5 Million
Monday, 14 Mar 2016 02:27pm EDT 

GeneNews Limited:Says that it is undertaking a non-brokered private placement of up to 50,000,000 common shares of the Company at a price of $0.10 per share.Any remaining unfunded portion of the Offering may be raised with issuance of a senior secured, collateralized convertible debenture.If needed, this convertible debenture would be issued with a term of 1 year from date of issue, interest accrued and payable at 15% and with a conversion price of $0.16 per Common Share.The conversion would become mandatory if the Common Shares trade above $0.16 for 30 consecutive trading days.  Full Article

GeneNews Limited acquires full control of innovative diagnostic laboratory
Friday, 4 Mar 2016 07:30am EST 

GeneNews Limited:Acquires full control of innovative diagnostic laboratory.Says will assume any and all of cobalt's liability relating to cobalt's $1 million secured demand promissory note.Says the purchasing agreement is subject to GeneNews completing a strategic financing during March 2016.Says no other consideration will be paid.Unit will acquire cobalt's fifty percent ownership interest in the innovative diagnostic laboratory joint-venture.Additionally, GeneNews has asked for and received a one year extension on the term of the note, making it due in May 2017.  Full Article

GeneNews Limited says initiated staff reduction of 16 employees, about 30 pct of workforce in IDL business - Reuters
Monday, 7 Dec 2015 09:05am EST 

GeneNews Limited:Says GeneNews has initiated a staff reduction of 16 employees, representing approximately 30% of IDL's total workforce.Says has entered into an interim working capital loan agreement with a major shareholder.Interim working capital financing provides GeneNews sufficient capital to support continuing operations "in the short-term".Interim working capital loan agreement pursuant to which co will borrow US$400,000, bearing interest of 2 percent, with term of one year.  Full Article

GeneNews raises $1.26 million in non-brokered private placement
Wednesday, 19 Aug 2015 04:30pm EDT 

GeneNews Ltd:It has accepted subscriptions for a non-brokered private placement offering of 3,956,249 units at a price of $0.32 per Unit for aggregate gross proceeds to the Company of $1,265,996.48 CAD.Each Unit is comprised of one common share and one warrant.Each Warrant is exercisable until September 15, 2017 and entitles the holder to purchase one Common Share at an exercise price of $0.50, subject to customary adjustment provisions.  Full Article

More From Around the Web

BRIEF-Genenews Q1 loss per share $0.02

* Genenews announces q1-2017 financial results & provides progress update

No consensus analysis data available.